DK0555336T3 - Homobifunktionelle midler til kobling af enzymer og lignende til antistoffer og lignende - Google Patents

Homobifunktionelle midler til kobling af enzymer og lignende til antistoffer og lignende

Info

Publication number
DK0555336T3
DK0555336T3 DK91920049.3T DK91920049T DK0555336T3 DK 0555336 T3 DK0555336 T3 DK 0555336T3 DK 91920049 T DK91920049 T DK 91920049T DK 0555336 T3 DK0555336 T3 DK 0555336T3
Authority
DK
Denmark
Prior art keywords
intrinsic factor
group
disclosed
solution
purified
Prior art date
Application number
DK91920049.3T
Other languages
English (en)
Inventor
Christopher Bieniarz
Christopher Welch
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK0555336T3 publication Critical patent/DK0555336T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91920049.3T 1990-10-22 1991-10-18 Homobifunktionelle midler til kobling af enzymer og lignende til antistoffer og lignende DK0555336T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60079590A 1990-10-22 1990-10-22

Publications (1)

Publication Number Publication Date
DK0555336T3 true DK0555336T3 (da) 1996-11-25

Family

ID=24405079

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91920049.3T DK0555336T3 (da) 1990-10-22 1991-10-18 Homobifunktionelle midler til kobling af enzymer og lignende til antistoffer og lignende

Country Status (12)

Country Link
US (1) US5380873A (da)
EP (1) EP0555336B1 (da)
JP (2) JP3360174B2 (da)
KR (1) KR930702683A (da)
AT (1) ATE140795T1 (da)
AU (1) AU657284B2 (da)
CA (1) CA2094397C (da)
DE (1) DE69121108T2 (da)
DK (1) DK0555336T3 (da)
ES (1) ES2092579T3 (da)
GR (1) GR3021097T3 (da)
WO (1) WO1992007268A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994020636A1 (en) * 1993-03-09 1994-09-15 Abbott Laboratories Genetically engineered enzymes and their conjugates for diagnostic assays
US5548064A (en) * 1993-05-24 1996-08-20 Biotech Australia Pty Limited Vitamin B12 conjugates with EPO, analogues thereof and pharmaceutical compositions
US6306665B1 (en) * 1999-10-13 2001-10-23 A-Fem Medical Corporation Covalent bonding of molecules to an activated solid phase material
US7193065B2 (en) * 2001-07-13 2007-03-20 Roche Diagnostics Operations, Inc. Protease inhibitor conjugates and antibodies useful in immunoassay
EP1877101B1 (en) 2005-04-28 2016-11-16 Ventana Medical Systems, Inc. Enzymes conjugated to antibodies via a peg heterobifuctional linker
JP4793714B2 (ja) * 2005-05-19 2011-10-12 独立行政法人産業技術総合研究所 新規クロスリンカー化合物
EP1951316B1 (en) 2005-11-23 2015-08-19 Ventana Medical Systems, Inc. Molecular conjugate
WO2008136769A1 (en) * 2007-05-03 2008-11-13 Nanyang Technological University Online contaminant detection and removal system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340387C (en) * 1987-10-30 1999-02-09 Carol A. Schlesinger Heterobifunctional coupling agents
US5066490A (en) * 1988-06-01 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Protein crosslinking reagents cleavable within acidified intracellular vesicles
US5104815A (en) * 1988-10-11 1992-04-14 Abbott Laboratories Assay for cobalamins
ES2104566T3 (es) * 1989-03-10 1997-10-16 Hoffmann La Roche Reactivos para la determinacion de drogas.

Also Published As

Publication number Publication date
JP3360174B2 (ja) 2002-12-24
WO1992007268A1 (en) 1992-04-30
CA2094397A1 (en) 1992-04-23
DE69121108D1 (de) 1996-08-29
EP0555336A1 (en) 1993-08-18
ES2092579T3 (es) 1996-12-01
JP2000229926A (ja) 2000-08-22
GR3021097T3 (en) 1996-12-31
JPH06502411A (ja) 1994-03-17
JP3488670B2 (ja) 2004-01-19
US5380873A (en) 1995-01-10
KR930702683A (ko) 1993-09-09
EP0555336A4 (en) 1994-10-12
AU8905991A (en) 1992-05-20
DE69121108T2 (de) 1997-02-27
ATE140795T1 (de) 1996-08-15
CA2094397C (en) 2005-10-04
AU657284B2 (en) 1995-03-09
EP0555336B1 (en) 1996-07-24

Similar Documents

Publication Publication Date Title
DE3067935D1 (en) Antitumor protein hybrid and process for the preparation thereof
ES8506902A1 (es) Un procedimiento para la purificacion de un antigeno.
NZ239617A (en) Pharmaceutical compositions containing cross-linked homoconjugated monoclonal antibodies having at least two igg antibodies which bind to the same determinant
ES8700672A1 (es) Un procedimiento para la preparacion de derivados de amino alquilentio-alquilentiofosfonatos.
FI960379A0 (fi) Lasikuitukoostumuksia
ES2065880T3 (es) Proteina quimicamente modificada y obtencion de la misma.
UA27763C2 (uk) Рекомбінантна молекула днк, що кодує молекулу адгезії icam-3, молекула адгезії icam-3, антитіло, здатне зв'язуватись з такою молекулою, фармацевтична композиція
DK0555336T3 (da) Homobifunktionelle midler til kobling af enzymer og lignende til antistoffer og lignende
FR2567596B1 (fr) Agrafe pour l'assemblage de pieces, telles que des panneaux
CA2172663A1 (en) Improved reagents for a cannabinoid immunoassay
DE3878804D1 (de) Pigmentzubereitungen, verfahren zu ihrer herstellung und ihre verwendung.
DK656488A (da) Praeparat med langvarig frigivelse indeholdende 1,4-dihydropyridinforbindelser
DE59010462D1 (de) Neue Cobalamin-Säurehydrazide und davon abgeleitete Cobalamin-Konjugate
FR2560212B1 (fr) Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
ATE20597T1 (de) Polymermischungen und diese enthaltende zusammensetzung.
Amaral et al. Human liver nuclear transcortin its postulated role in glucocorticoid regulation of genetic activity
DE68906279D1 (de) Fluorkohlenstoffkette enthaltende antigene konjugate.
ATE15047T1 (de) Galactopyranoside verbindungen, verfahren zu ihrer herstellung und ihre verwendung als antigene oder immunadsorbentien.
ES8608685A1 (es) Procedimiento de preparar anticuerpos monoclonales y metodo de preparar reactivos para detectar canceres
ES2082132T3 (es) Composicion que contiene al menos dos anticuerpos distintos o fragmentos de ellos.
DK0937092T3 (da) Faste bærematrixer indeholdende et oligosaccharid, som binder toksiner
ATE395361T1 (de) Das h-y antigen
ATE69444T1 (de) N-substituierte-n-nitroso-aminoacetonitrile, verfahren zu ihrer herstellung und ihre verwendung.
MIYAZAKI et al. Preparation of antibody (IgG)-ricin A-chain conjugate and its biologic activity
Hudson et al. The use of column-bound B lymphocytes for absorption of antisera to T lymphocyte antigens